Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Polycystic Ovary Syndrome × Probiotics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 5 Breast Neoplasms 4 Stomach Neoplasms 3 Neoplasms 2 Mucositis 2 Malnutrition 2 Lung Neoplasms 2 Diarrhea 2 Chalazion 2 Carcinoma, Hepatocellular 2 Thyroid Neoplasms 1 Squamous Intraepithelial Lesions 1 Smoldering Multiple Myeloma 1 Psychological Well-Being 1 Polycystic Ovary Syndrome 1 Periampullary Carcinoma Nos 1 Pelvic Neoplasms 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neoplasms, Second Primary 1 Muscle Invasive Bladder Cancer (MIBC) 1 Multiple Myeloma 1 Motor Activity 1 Monoclonal Gammopathy of Undetermined Significance 1 Liver Cirrhosis 1 Limited Stage Small Cell Lung Cancer 1 Laryngeal Neoplasms 1 Infections 1 Helicobacter Infections 1 Generalized Anxiety Disorder 1

Interventions

Metformin 122 Clomiphene 39 Letrozole 32 Inositol 24 Progesterone 15 Folic Acid 15 Exercise 14 drospirenone and ethinyl estradiol combination 12 Ethinyl Estradiol 12 Caloric Restriction 12 Estradiol 11 Contraceptives, Oral 11 cetrorelix 10 Chorionic Gonadotropin 10 Triptorelin Pamoate 9 Pioglitazone 9 Tablets 8 Spironolactone 8 High-Intensity Interval Training 8 Diet 8 Cholecalciferol 8 Menotropins 7 Gonadotropins 7 Acupuncture Therapy 7 drospirenone 6 Thioctic Acid 6 Ovidrel 6 Liraglutide 6 Flutamide 6 Exenatide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04593459 2024-03-22

ProPCO-RCT

Medical University of Graz

Phase 4 Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡